GRAL
GRAIL, Inc.
Price Chart
Latest Quote
$61.11
-0.99 (-1.59%)
Current Price
| Previous Close | $62.10 |
| Open | $60.00 |
| Day High | $63.82 |
| Day Low | $60.00 |
| Volume | 421,126 |
Stock Information
| Shares Outstanding | 42.92M |
| Total Debt | $51.03M |
| Cash Equivalents | $823.11M |
| Revenue | $156.12M |
| Net Income | $-395.32M |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Market Cap | $2.62B |
| EPS (TTM) | $-10.30 |
| Exchange | NMS |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $1.85B |
| Sales | $156.12M |
| Income | $-395.32M |
| Book/sh | $60.79 |
| Cash/sh | $19.18 |
| Employees | 910 |
Financial Ratios
| Quick Ratio | 11.29 |
| Current Ratio | 11.74 |
| Debt/Eq | 2.04 |
Returns & Margins
| ROA | -11.42% |
| ROE | -16.09% |
| Gross Margin | 49.28% |
| Operating Margin | -332.88% |
| Profit Margin | -253.22% |
Ownership
| Insider Ownership | 5.17% |
| Institutional Ownership | 83.57% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -6.29 |
| P/S | 16.80 |
| P/B | 1.01 |
Analyst Data
| Recommendation | buy |
| Target Price | $66.00 |
Technical Indicators
| SMA20 | $63.17 |
| SMA50 | $59.27 |
| SMA200 | $71.74 |
| RSI | 52.07 |
| ATR | 4.4499 |
| Shares Float | 33.53M |
| Short Float | 15.06% |
| Short Ratio | 9.56 |
| Volatility | 3.16 |
| Rel Volume | 0.47 |
Performance History
| Week | +2.17% |
| Month | -9.95% |
| Quarter | +24.38% |
| 6 Months | -30.80% |
| YTD | -31.24% |
| Year | +33.93% |
| 10 Years | +347.36% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-23 | $61.11 | 421,100 |
| 2026-06-22 | $62.10 | 527,500 |
| 2026-06-18 | $63.74 | 1,164,500 |
| 2026-06-17 | $59.45 | 689,200 |
| 2026-06-16 | $58.29 | 414,800 |
| 2026-06-15 | $59.81 | 668,400 |
| 2026-06-12 | $59.85 | 343,900 |
| 2026-06-11 | $60.16 | 596,700 |
| 2026-06-10 | $58.59 | 794,300 |
| 2026-06-09 | $60.90 | 556,500 |
| 2026-06-08 | $61.52 | 659,400 |
| 2026-06-05 | $59.98 | 760,300 |
| 2026-06-04 | $66.55 | 1,276,400 |
| 2026-06-03 | $61.13 | 799,000 |
| 2026-06-02 | $59.90 | 1,587,200 |
| 2026-06-01 | $64.40 | 2,612,600 |
| 2026-05-29 | $71.68 | 1,247,700 |
| 2026-05-28 | $73.92 | 1,079,900 |
| 2026-05-27 | $71.42 | 661,100 |
| 2026-05-26 | $68.96 | 935,400 |
About GRAIL, Inc.
GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients with clinical suspicion of cancer. The company also provides development services, including support for ongoing clinical studies, pilot testing, research, and therapy development. In addition, its precision oncology portfolio consists of n RUO-targeted methylation-based platform that enables applications for disease prognostication, risk stratification, minimal residual disease detection, and recurrence and relapse monitoring. The company was incorporated in 2015 and is headquartered in Menlo Park, California.
đ° Latest News
Honeywell Stock Is Likely to Reward Shareholders Following Quantinuum IPO, Split
Barchart âĸ 2026-06-04T13:35:02Z
A Look At GRAIL (GRAL) Valuation After A Sharp One Day Share Price Drop
Simply Wall St. âĸ 2026-06-02T21:18:59Z
Grail Plummets On Mixed Results For Cancer-Screening Blood Test
Investor's Business Daily âĸ 2026-06-01T20:32:39Z
GRAIL (GRAL) Is Up 6.7% After Mixed Galleri Trial Data At ASCO 2026 - Has The Bull Case Changed?
Simply Wall St. âĸ 2026-06-01T17:12:07Z
GRAIL, Inc. (GRAL): One of the Best Stock Picks of Jeff Bezos
Insider Monkey âĸ 2026-06-01T17:11:43Z
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Monday as AI Optimism Overshadows Middle East Risks
MT Newswires âĸ 2026-06-01T13:03:10ZGRAILâs Galleri Test Cuts Stage 4 Cancer Diagnoses in Study Despite Missed Endpoint
MarketBeat âĸ 2026-06-01T01:03:17Z
GRAIL Says Galleri Demand Is Rising as NHS Talks, FDA Review Move Ahead
MarketBeat âĸ 2026-05-17T16:02:12Z
How The GRAIL (GRAL) Narrative Is Shifting After NHS Galleri Results And Reimbursement Questions
Simply Wall St. âĸ 2026-05-08T10:13:02Z
GRAIL Q1 Earnings Call Highlights
MarketBeat âĸ 2026-05-06T00:38:30Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $209,745,000 | $203,617,000 | $188,716,000 | $171,997,000 |
| Cost Of Revenue | $209,745,000 | $203,617,000 | $188,716,000 | $171,997,000 |
| Total Revenue | $147,172,000 | $125,595,000 | $93,105,000 | $55,550,000 |
| Operating Revenue | $147,172,000 | $125,595,000 | $93,105,000 | $55,550,000 |
| Expenses | ||||
| Total Expenses | $681,335,000 | $893,817,000 | $890,021,000 | $798,009,000 |
| Other Income Expense | $-28,993,000 | $-1,420,872,000 | $-718,674,000 | $-4,700,669,000 |
| Other Non Operating Income Expenses | $-993,000 | $64,000 | $-208,000 | $-238,000 |
| Net Non Operating Interest Income Expense | $28,652,000 | $26,733,000 | $7,954,000 | $1,740,000 |
| Operating Expense | $471,590,000 | $690,200,000 | $701,305,000 | $626,012,000 |
| Selling And Marketing Expense | $116,693,000 | $153,958,000 | $162,292,000 | $122,328,000 |
| General And Administrative Expense | $159,103,000 | $213,862,000 | $200,268,000 | $174,108,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-408,351,000 | $-2,027,005,000 | $-1,465,685,000 | $-5,399,098,000 |
| Net Interest Income | $28,652,000 | $26,733,000 | $7,954,000 | $1,740,000 |
| Interest Income | $28,652,000 | $26,733,000 | $7,954,000 | $1,740,000 |
| Normalized Income | $-386,959,527 | $-695,014,469 | $-767,210,806 | $-735,198,346 |
| Net Income From Continuing And Discontinued Operation | $-408,351,000 | $-2,027,005,000 | $-1,465,685,000 | $-5,399,098,000 |
| Total Operating Income As Reported | $-562,163,000 | $-2,189,158,000 | $-1,515,382,000 | $-5,442,890,000 |
| Net Income Common Stockholders | $-408,351,000 | $-2,027,005,000 | $-1,465,685,000 | $-5,399,098,000 |
| Net Income | $-408,351,000 | $-2,027,005,000 | $-1,465,685,000 | $-5,399,098,000 |
| Net Income Including Noncontrolling Interests | $-408,351,000 | $-2,027,005,000 | $-1,465,685,000 | $-5,399,098,000 |
| Net Income Continuous Operations | $-408,351,000 | $-2,027,005,000 | $-1,465,685,000 | $-5,399,098,000 |
| Pretax Income | $-534,504,000 | $-2,162,361,000 | $-1,507,636,000 | $-5,441,388,000 |
| Special Income Charges | $-28,000,000 | $-1,420,936,000 | $-718,466,000 | $-4,700,431,000 |
| Interest Income Non Operating | $28,652,000 | $26,733,000 | $7,954,000 | $1,740,000 |
| Operating Income | $-534,163,000 | $-768,222,000 | $-796,916,000 | $-742,459,000 |
| Gross Profit | $-62,573,000 | $-78,022,000 | $-95,611,000 | $-116,447,000 |
| Per Share | ||||
| Diluted EPS | $-11.11 | $-63.54 | $-47.21 | $-173.89 |
| Basic EPS | $-11.11 | $-63.54 | $-47.21 | $-173.89 |
| Other | ||||
| Tax Effect Of Unusual Items | $-6,608,527 | $-88,945,469 | $-19,991,806 | $-36,531,346 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-349,819,000 | $810,770,000 | $80,247,000 | $4,112,735,000 |
| Total Unusual Items | $-28,000,000 | $-1,420,936,000 | $-718,466,000 | $-4,700,431,000 |
| Total Unusual Items Excluding Goodwill | $-28,000,000 | $-1,420,936,000 | $-718,466,000 | $-4,700,431,000 |
| Reconciled Depreciation | $156,344,000 | $158,056,000 | $158,697,000 | $154,763,000 |
| EBITDA (Bullshit earnings) | $-377,819,000 | $-610,166,000 | $-638,219,000 | $-587,696,000 |
| EBIT | $-534,163,000 | $-768,222,000 | $-796,916,000 | $-742,459,000 |
| Diluted Average Shares | $36,753,751 | $31,901,259 | $31,049,148 | $31,049,148 |
| Basic Average Shares | $36,753,751 | $31,901,259 | $31,049,148 | $31,049,148 |
| Diluted NI Availto Com Stockholders | $-408,351,000 | $-2,027,005,000 | $-1,465,685,000 | $-5,399,098,000 |
| Tax Provision | $-126,153,000 | $-135,356,000 | $-41,951,000 | $-42,290,000 |
| Impairment Of Capital Assets | $28,000,000 | $1,420,936,000 | $718,466,000 | $4,700,431,000 |
| Research And Development | $195,794,000 | $322,380,000 | $338,745,000 | $329,576,000 |
| Selling General And Administration | $275,796,000 | $367,820,000 | $362,560,000 | $296,436,000 |
| Other Gand A | $159,103,000 | $213,862,000 | $200,268,000 | $174,108,000 |
Fetched: 2026-06-22
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $727,306,000 | $486,515,000 | $-3,576,159,000 | $-4,432,958,000 |
| Total Assets | $2,922,015,000 | $2,983,307,000 | $3,913,814,000 | $4,937,986,000 |
| Total Non Current Assets | $1,968,166,000 | $2,163,446,000 | $3,757,749,000 | $4,642,353,000 |
| Other Non Current Assets | $13,727,000 | $11,122,000 | $12,209,000 | $10,672,000 |
| Goodwill And Other Intangible Assets | $1,850,556,000 | $2,016,890,000 | $3,576,159,000 | $4,432,958,000 |
| Other Intangible Assets | $1,850,556,000 | $2,016,890,000 | $2,687,223,000 | $2,935,556,000 |
| Current Assets | $953,849,000 | $819,861,000 | $156,065,000 | $295,633,000 |
| Other Current Assets | $15,107,000 | $17,447,000 | $20,100,000 | $18,655,000 |
| Inventory | $16,017,000 | $18,632,000 | $21,695,000 | $19,755,000 |
| Receivables | $18,295,000 | $20,312,000 | $23,736,000 | $19,765,000 |
| Accounts Receivable | $18,295,000 | $20,312,000 | $16,942,000 | $15,346,000 |
| Allowance For Doubtful Accounts Receivable | $-3,604,000 | $-3,800,000 | $-3,100,000 | - |
| Gross Accounts Receivable | $21,899,000 | $24,112,000 | $20,042,000 | $15,346,000 |
| Cash Cash Equivalents And Short Term Investments | $904,430,000 | $763,470,000 | $97,287,000 | $241,596,000 |
| Cash And Cash Equivalents | $249,727,000 | $214,234,000 | $97,287,000 | $241,596,000 |
| Prepaid Assets | - | $12,973,000 | $13,347,000 | $14,517,000 |
| Taxes Receivable | - | $4,474,000 | $6,794,000 | $4,138,000 |
| Debt | ||||
| Total Debt | $54,863,000 | $68,141,000 | $84,407,000 | $96,010,000 |
| Long Term Debt And Capital Lease Obligation | $43,148,000 | $54,881,000 | $69,598,000 | $82,675,000 |
| Current Debt And Capital Lease Obligation | $11,715,000 | $13,260,000 | $14,809,000 | $13,335,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $344,153,000 | $479,902,000 | $267,627,000 | $291,825,000 |
| Total Non Current Liabilities Net Minority Interest | $264,483,000 | $402,977,000 | $104,017,000 | $156,884,000 |
| Other Non Current Liabilities | $2,752,000 | $2,236,000 | $1,498,000 | $3,134,000 |
| Non Current Deferred Liabilities | $218,583,000 | $345,860,000 | $32,921,000 | $71,075,000 |
| Non Current Deferred Taxes Liabilities | $218,583,000 | $345,860,000 | $32,921,000 | $71,075,000 |
| Current Liabilities | $79,670,000 | $76,925,000 | $163,610,000 | $134,941,000 |
| Other Current Liabilities | $1,927,000 | $1,580,000 | $809,000 | $3,112,000 |
| Payables And Accrued Expenses | $29,729,000 | $27,555,000 | $51,995,000 | $44,390,000 |
| Payables | $2,083,000 | $4,844,000 | $19,673,000 | $17,481,000 |
| Accounts Payable | $2,083,000 | $4,844,000 | $19,673,000 | $15,189,000 |
| Equity | ||||
| Common Stock Equity | $2,577,862,000 | $2,503,405,000 | $3,646,187,000 | $4,646,161,000 |
| Total Equity Gross Minority Interest | $2,577,862,000 | $2,503,405,000 | $3,646,187,000 | $4,646,161,000 |
| Stockholders Equity | $2,577,862,000 | $2,503,405,000 | $0 | $0 |
| Gains Losses Not Affecting Retained Earnings | $2,655,000 | $1,451,000 | $1,066,000 | $894,000 |
| Other Equity Adjustments | $2,655,000 | $1,451,000 | - | - |
| Retained Earnings | $-10,211,681,000 | $-9,803,330,000 | $-7,776,325,000 | $-6,310,640,000 |
| Other | ||||
| Ordinary Shares Number | $40,331,360 | $33,893,409 | $31,100,000 | $31,100,000 |
| Share Issued | $40,331,360 | $33,893,409 | $31,100,000 | $31,100,000 |
| Tangible Book Value | $727,306,000 | $486,515,000 | $70,028,000 | $213,203,000 |
| Invested Capital | $2,577,862,000 | $2,503,405,000 | $3,646,187,000 | $4,646,161,000 |
| Working Capital | $874,179,000 | $742,936,000 | $-7,545,000 | $160,692,000 |
| Capital Lease Obligations | $54,863,000 | $68,141,000 | $84,407,000 | $96,010,000 |
| Total Capitalization | $2,577,862,000 | $2,503,405,000 | $3,646,187,000 | $4,646,161,000 |
| Additional Paid In Capital | $12,786,848,000 | $12,305,250,000 | - | - |
| Capital Stock | $40,000 | $34,000 | - | - |
| Common Stock | $40,000 | $34,000 | - | - |
| Preferred Stock | $0 | $0 | - | - |
| Long Term Capital Lease Obligation | $43,148,000 | $54,881,000 | $69,598,000 | $82,675,000 |
| Current Capital Lease Obligation | $11,715,000 | $13,260,000 | $14,809,000 | $13,335,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $36,299,000 | $34,530,000 | $95,997,000 | $74,104,000 |
| Current Accrued Expenses | $27,646,000 | $22,711,000 | $32,322,000 | $26,909,000 |
| Net PPE | $103,883,000 | $135,434,000 | $169,381,000 | $198,723,000 |
| Accumulated Depreciation | $-70,453,000 | $-53,880,000 | $-35,545,000 | $-19,003,000 |
| Gross PPE | $174,336,000 | $189,314,000 | $204,926,000 | $217,726,000 |
| Leases | $59,769,000 | $59,764,000 | $58,439,000 | $55,412,000 |
| Construction In Progress | $804,000 | $1,296,000 | $7,966,000 | $10,648,000 |
| Other Properties | $106,183,000 | $119,923,000 | $130,906,000 | $141,447,000 |
| Machinery Furniture Equipment | $7,580,000 | $8,331,000 | $7,615,000 | $10,219,000 |
| Properties | $0 | $0 | $0 | $0 |
| Raw Materials | $16,017,000 | $18,632,000 | $21,695,000 | $19,755,000 |
| Other Short Term Investments | $654,703,000 | $549,236,000 | $0 | - |
| Goodwill | - | $0 | $888,936,000 | $1,497,402,000 |
| Total Partnership Capital | - | - | $3,646,187,000 | $4,646,161,000 |
| Limited Partnership Capital | - | - | $11,421,446,000 | $10,955,907,000 |
| Dueto Related Parties Current | - | - | $828,000 | $2,292,000 |
| Duefrom Related Parties Current | - | - | $121,000 | $281,000 |
Fetched: 2026-06-22
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-299,916,000 | $-582,364,000 | $-608,687,000 | $-584,172,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-299,007,000 | $-577,156,000 | $-595,800,000 | $-561,313,000 |
| Cash Flow From Continuing Operating Activities | $-299,007,000 | $-577,156,000 | $-595,800,000 | $-561,313,000 |
| Investing Activities | ||||
| Capital Expenditure | $-909,000 | $-5,208,000 | $-12,887,000 | $-22,859,000 |
| Investing Cash Flow | $-85,049,000 | $-551,011,000 | $-12,887,000 | $-22,859,000 |
| Cash Flow From Continuing Investing Activities | $-85,049,000 | $-551,011,000 | $-12,887,000 | $-22,859,000 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $418,796,000 | $0 | $0 | - |
| Financing Cash Flow | $423,321,000 | $1,244,300,000 | $463,766,000 | $604,817,000 |
| Cash Flow From Continuing Financing Activities | $423,321,000 | $1,244,300,000 | $463,766,000 | $604,817,000 |
| Net Common Stock Issuance | $418,796,000 | $0 | $0 | - |
| Common Stock Issuance | $418,796,000 | $0 | $0 | - |
| Net Other Financing Charges | - | $1,244,300,000 | $463,766,000 | $604,817,000 |
| Other | ||||
| End Cash Position | $256,701,000 | $217,583,000 | $101,512,000 | $246,128,000 |
| Beginning Cash Position | $217,583,000 | $101,512,000 | $246,128,000 | $225,994,000 |
| Effect Of Exchange Rate Changes | $-147,000 | $-62,000 | $305,000 | $-511,000 |
| Changes In Cash | $39,265,000 | $116,133,000 | $-144,921,000 | $20,645,000 |
| Proceeds From Stock Option Exercised | $4,525,000 | $0 | $0 | $0 |
| Net Investment Purchase And Sale | $-84,140,000 | $-545,803,000 | $0 | $0 |
| Sale Of Investment | $1,224,200,000 | $0 | $0 | $0 |
| Purchase Of Investment | $-1,308,340,000 | $-545,803,000 | $0 | $0 |
| Net PPE Purchase And Sale | $-909,000 | $-5,208,000 | $-12,887,000 | $-22,859,000 |
| Purchase Of PPE | $-909,000 | $-5,208,000 | $-12,887,000 | $-22,859,000 |
| Change In Working Capital | $12,408,000 | $-24,278,000 | $7,721,000 | $-14,464,000 |
| Change In Other Working Capital | $1,025,000 | $1,747,000 | $6,712,000 | $4,924,000 |
| Change In Payables And Accrued Expense | $3,723,000 | $-27,551,000 | $5,240,000 | $13,896,000 |
| Change In Accrued Expense | $6,456,000 | $-12,916,000 | $2,351,000 | $11,556,000 |
| Change In Payable | $-2,733,000 | $-14,635,000 | $2,889,000 | $2,340,000 |
| Change In Account Payable | $-2,733,000 | $-14,635,000 | $2,889,000 | $2,340,000 |
| Change In Prepaid Assets | $3,360,000 | $1,823,000 | $-908,000 | $-10,526,000 |
| Change In Inventory | $2,615,000 | $3,073,000 | $-1,940,000 | $-14,082,000 |
| Change In Receivables | $1,685,000 | $-3,370,000 | $-1,383,000 | $-8,676,000 |
| Changes In Account Receivables | $1,685,000 | $-3,370,000 | $-1,383,000 | $-8,676,000 |
| Other Non Cash Items | $1,347,000 | $-53,531,000 | $-74,081,000 | $-39,611,000 |
| Stock Based Compensation | $58,283,000 | $86,084,000 | $97,235,000 | $75,729,000 |
| Asset Impairment Charge | $28,332,000 | $1,420,936,000 | $718,466,000 | $4,700,431,000 |
| Amortization Of Securities | $-21,217,000 | $-3,167,000 | $0 | $0 |
| Deferred Tax | $-126,153,000 | $-134,251,000 | $-38,153,000 | $-39,063,000 |
| Deferred Income Tax | $-126,153,000 | $-134,251,000 | $-38,153,000 | $-39,063,000 |
| Depreciation Amortization Depletion | $156,344,000 | $158,056,000 | $158,697,000 | $154,763,000 |
| Depreciation And Amortization | $156,344,000 | $158,056,000 | $158,697,000 | $154,763,000 |
| Amortization Cash Flow | $138,334,000 | $138,333,000 | $138,333,000 | $138,333,000 |
| Amortization Of Intangibles | $138,334,000 | $138,333,000 | $138,333,000 | $138,333,000 |
| Depreciation | $18,010,000 | $19,723,000 | $20,364,000 | $16,430,000 |
| Net Income From Continuing Operations | $-408,351,000 | $-2,027,005,000 | $-1,465,685,000 | $-5,399,098,000 |
Fetched: 2026-06-22